Gustafsson Berit M, Korhonen Laura
Linköping University, Department of Child and Adolescent Psychiatry, Department of Biomedical and Clinical Sciences, Linkoping, Sweden.
JMIR Res Protoc. 2022 Jun 15;11(6):e34969. doi: 10.2196/34969.
Neurodevelopmental difficulties with various emotional and behavioral symptoms increase the risk of mental health problems later in life. Although we know that early detection and interventions are effective, there is a lack of intersectoral, integrative, and evidence-based working models to provide these services for preschool children and their parents. PLUSS (Psykisk hälsa Lärande Utveckling Samverkan kring Små barn; English translation: mental health, learning, development, collaboration around preschool children) is a collaborative "one way in" model involving parents, health care providers, preschools, social services, and researchers. PLUSS provides coordinated services to screen, evaluate, and support toddlers with neurodevelopmental problems. It also offers parental interventions and education for preschool teachers.
The model will be studied in a research project that aims to investigate (1) using a quasi-experimental study on longitudinal trajectories of neurodevelopmental difficulties and ability to function among participating preschoolers, (2) user satisfaction, and (3) implementation of the model and its effectiveness. The long-term goal is to provide evidence-based, coordinated services to reduce problems related to neurodevelopmental difficulties among preschool children and promote well-being and functioning in everyday life.
The population of interest is children aged 1.5-5 years, whom the child health care nurse refers for further assessment due to suspected neurodevelopmental problems. Data are collected using questionnaires and semistructured interviews. Measures include sociodemographic data, longitudinal data on neurodevelopmental problems, parental well-being and satisfaction, the effectiveness of parental and preschool teacher training and implementation of the model, and fostered multisectoral collaborations. Data will be analyzed with qualitative and quantitative methods.
The PLUSS model has been approved by the National Ethics Review Board (2019-04839). This study was supported by FUTURUM grants 910161 and 910441. Data collection started in April 2019, with the data collection period planned to end in May 2024.
PLUSS is an integrative working model with multiprofessional competence and intersectoral collaboration capacity to help preschool children with neurodevelopmental problems and their parents. It will be studied using quasi-experimental cross-sectional and longitudinal study designs. Data will be collected from parents, health care providers, and preschool teachers, and will be analyzed using quantitative and qualitative methods. The study will run in one Swedish county, and generalizability needs to be studied separately. Loss of follow-up could impact the longitudinal analysis.
ClinicalTrials.gov NCT04815889; https://clinicaltrials.gov/ct2/show/NCT04815889.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/34969.
伴有各种情绪和行为症状的神经发育困难会增加日后出现心理健康问题的风险。尽管我们知道早期发现和干预是有效的，但缺乏跨部门、综合且基于证据的工作模式来为学龄前儿童及其父母提供这些服务。PLUSS（瑞典语：Psykisk hälsa Lärande Utveckling Samverkan kring Små barn；英语翻译：mental health, learning, development, collaboration around preschool children，即围绕学龄前儿童的心理健康、学习、发展与合作）是一种合作性的“一站式”模式，涉及父母、医疗保健提供者、幼儿园、社会服务机构和研究人员。PLUSS提供协调服务，以筛查、评估和支持有神经发育问题的幼儿。它还为幼儿园教师提供家长干预措施和教育。
该模式将在一个研究项目中进行研究，旨在调查：（1）通过对参与研究的学龄前儿童神经发育困难的纵向轨迹和功能能力进行准实验研究；（2）用户满意度；（3）该模式的实施情况及其有效性。长期目标是提供基于证据的协调服务，以减少学龄前儿童与神经发育困难相关的问题，并促进其在日常生活中的幸福感和功能。
研究对象为1.5至5岁的儿童，这些儿童因疑似神经发育问题被儿童保健护士转介进行进一步评估。数据通过问卷调查和半结构化访谈收集。测量指标包括社会人口统计学数据、神经发育问题的纵向数据、父母的幸福感和满意度、家长和幼儿园教师培训的有效性以及该模式的实施情况，以及促进的多部门合作。数据将采用定性和定量方法进行分析。
PLUSS模式已获得国家伦理审查委员会批准（2019 - 04839）。本研究得到了未来基金910161和910441的支持。数据收集于2019年4月开始，计划数据收集期于2024年5月结束。
PLUSS是一种具有多专业能力和跨部门协作能力的综合工作模式，可帮助有神经发育问题的学龄前儿童及其父母。将使用准实验性横断面和纵向研究设计对其进行研究。数据将从父母、医疗保健提供者和幼儿园教师处收集，并将采用定量和定性方法进行分析。该研究将在瑞典的一个县进行，普遍性需要单独研究。随访失访可能会影响纵向分析。
ClinicalTrials.gov NCT04815889；https://clinicaltrials.gov/ct2/show/NCT04815889。
国际注册报告识别码（IRRID）：DERR1 - 10.2196/34969。
